Bioventures Investors

We believe that investing in private equity provides a means of participating in the dynamic commercial development of new life-science technology with a degree of insulation from the public markets. Surging interest in genomics and basic medical research is feeding a remarkable expansion of our understanding of biological systems, which in turn creates a watershed for commercial development. Demand for new products from both consumers and from market-focused, healthcare corporations should continue to drive a seller's market for new ideas into the foreseeable future. These factors create an outstanding opportunity for the informed investor.